Epidermal growth factor receptor (EGFR), also known as HER1 or ERBB1, a transmembrane receptor tyrosine kinase (RTK), is commonly altered in GBM through mutations, rearrangements, splicing, and amplifications, playing a key role in cell division, migration, and apoptosis [10,35]. This evidence concerns the gene EGFR and glioblastoma.